about
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic AdenocarcinomaPancreatic Cancer, A Mis-interpreter of the Epigenetic LanguageNonfunctional pancreatic neuroendocrine tumor masked as anemia: A case report.Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy.Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine.Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy.MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
P2860
Q27853365-E0FF9B44-F627-4CA5-BABF-2BBDDC7B19B5Q28079735-469BCA5E-3366-4FD0-A8B7-848ED198386BQ33885900-5FF9DFDB-6B3B-4893-9D42-E1CE876365BBQ38856634-6A234758-1366-4C57-9259-CBF3E60CCBF8Q47099526-CEFE1007-ABB9-45FC-8A34-69086EB300EEQ47209071-911A0481-9862-4079-B0EC-F8CA04791388Q58801376-B18A8DD2-B85F-4FBE-A1FB-40D4921B45F9
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pancreatic cancer, treatment options, and GI-4000.
@ast
Pancreatic cancer, treatment options, and GI-4000.
@en
type
label
Pancreatic cancer, treatment options, and GI-4000.
@ast
Pancreatic cancer, treatment options, and GI-4000.
@en
prefLabel
Pancreatic cancer, treatment options, and GI-4000.
@ast
Pancreatic cancer, treatment options, and GI-4000.
@en
P2093
P2860
P1476
Pancreatic cancer, treatment options, and GI-4000.
@en
P2093
John L Marshall
Leonel Ampie
Marion L Hartley
Najeebah A Bade
Petra A Prins
P2860
P304
P356
10.1080/21645515.2015.1011017
P577
2015-01-01T00:00:00Z